Pulmonary Embolism Following Covishield (ChADOx1 nCov-19) Vaccine: An Unusual Presentation
Abstract: Pulmonary embolism is a medical emergency. Most common risk factors-immobility, malignancy, pregnancy, surgery, cigarette smoking, hypertension, obesity and in Indian population hyperhomocysteinemia. COVID infection represents a prothrombotic state but introduction of COVID vaccines to a lesser extent increased the risk of unprovoked venous thrombosis and pulmonary thrombosis.
Keywords: COVID vaccine, pulmonary embolism
How to Cite?: Dr Sushant P Wagaj, Dr. C. A. Kante, "Pulmonary Embolism Following Covishield (ChADOx1 nCov-19) Vaccine: An Unusual Presentation", Volume 12 Issue 1, January 2023, International Journal of Science and Research (IJSR), Pages: 853-854, https://www.ijsr.net/getabstract.php?paperid=SR22522204713, DOI: https://dx.doi.org/10.21275/SR22522204713